文献速递妇科

组织病理图像联合多组学预测高级别浆液性卵巢癌分子特征与预后

Integration of histopathological images and multi-dimensional omics analyses predicts molecular features and prognosis in high-grade serous ovarian cancer.
PubMed 文献 · Gynecol Oncol · 2021-07-16

本研究利用TCGA数据(训练集115例、测试集114例)及92例组织芯片外部验证集,从组织病理图像提取定量特征,用机器学习建立模型预测HGSOC分子特征和总生存。图像特征可预测BRCA1/2突变、MSI状态和分子亚型,多组学整合模型5年AUC达0.911,高风险与低风险组生存差异显著(HR=18.23,p<0.001)。

要点

  • 图像特征可预测BRCA1突变(AUC=0.952)、BRCA2突变(AUC=0.912)等分子特征
  • 图像特征预后模型预测OS的5年AUC在测试集为0.825,验证集为0.703
  • 图像联合多组学模型预测OS最佳,5年AUC=0.911,高低风险组HR=18.23

核心结论

  • 组织病理图像特征有潜力预测HGSOC患者的分子特征和生存风险。
  • 图像特征与多组学数据整合可能改善HGSOC患者的预后预测。

研究设计与样本

  • 研究纳入TCGA患者,分为训练集115例和测试集114例。
  • 另收集92例患者组织芯片作为外部验证集。
  • 使用CellProfiler从组织病理图像提取定量特征,在训练集用机器学习建立预测模型。
  • 在测试集和验证集评估预测性能。

主要发现

  • 测试集中预测BRCA1突变AUC=0.952,BRCA2突变AUC=0.912。
  • 测试集中预测MSI-H的AUC=0.919,MSS的AUC=0.924。
  • 测试集中预测分子亚型:增殖型AUC=0.961、分化型AUC=0.952、免疫反应型AUC=0.941、间质型AUC=0.918。
  • 基于图像特征的预后模型预测OS的5年AUC在测试集为0.825,验证集为0.703。
  • 测试集中图像特征联合基因组学模型5年AUC=0.834,包含全部特征的多组学模型5年AUC=0.911,高低风险组生存差异显著(HR=18.23,p<0.001)。

临床怎么用

  • 可探索利用常规组织病理图像辅助预测HGSOC的BRCA突变状态、MSI状态和分子亚型。
  • 整合图像特征与多组学数据可能提升HGSOC预后分层能力。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: This study used histopathological image features to predict molecular features, and combined with multi-dimensional omics data to predict overall survival (OS) in high-grade serous ovarian cancer (HGSOC). METHODS: Patients from The Cancer Genome Atlas (TCGA) were distributed into training set (n = 115) and test set (n = 114). In addition, we collected tissue microarrays of 92 patients as an external validation set. Quantitative features were extracted from histopathological images using CellProfiler, and utilized to establish prediction models by machine learning methods in training set. The prediction performance was assessed in test set and validation set. RESULTS: The prediction models were able to identify BRCA1 mutation (AUC = 0.952), BRCA2 mutation (AUC = 0.912), microsatellite instability-high (AUC = 0.919), microsatellite stable (AUC = 0.924), and molecular subtypes: proliferative (AUC = 0.961), differentiated (AUC = 0.952), immunoreactive (AUC = 0.941), mesenchymal (AUC = 0.918) in test set. The prognostic model based on histopathological image features could predict OS in test set (5-year AUC = 0.825) and validation set (5-year AUC = 0.703). We next explored the integrative prognostic models of image features, genomics, transcriptomics and proteomics. In test set, the models combining two omics had higher prediction accuracy, such as image features and genomics (5-year AUC = 0.834). The multi-omics model including all features showed the best prediction performance (5-year AUC = 0.911). According to risk score of multi-omics model, the high-risk and low-risk groups had significant survival differences (HR = 18.23, p < 0.001). CONCLUSIONS: These results indicated the potential ability of histopathological image features to predict above molecular features and survival risk of HGSOC patients. The integration of image features and multi-omics data may improve prognosis prediction in HGSOC patients.

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. Zeng H, Chen L, Zhang M, et al. Integration of histopathological images and multi-dimensional omics analyses predicts molecular features and prognosis in high-grade serous ovarian cancer. Gynecol Oncol. 2021. PMID: 34275655. doi:10.1016/j.ygyno.2021.07.015

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。